News - Tobi Podhaler, Antibiotics and Infectious diseases


Popular Filters

FDA approves Novartis' TOBI Podhaler and Cangene's first Botulism Antitoxin heptavalent


The US Food and Drug Administration on Friday approved Swiss drug major Novartis' (NOVN: VX) TOBI Podhaler…

Antibiotics and Infectious diseasesBotulism antitoxinCangeneNorth AmericaNovartisPharmaceuticalRegulationRespiratory and PulmonaryTobi Podhaler

NICE "green light" for Novartis' Tobi Podhaler and Forest's Colobreathe


The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE), in a final draft…

Antibiotics and Infectious diseasesColoBreatheEuropeForest LaboratoriesNovartisPharmaceuticalPricingRare diseasesRegulationTobi Podhaler

Back to top